Bárbara Parente

Sacituzumab Govitecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non–Small Cell Lung Cancer: The Randomized, Open-Label Phase III EVOKE-01 Study

Luis Paz‐Ares, Óscar Juan, Giannis Mountzios et al. · Journal of Clinical Oncology · 2024 · 91 citations · Full text

Safety, Resource Use, and Quality of Life in Paramount: A Phase III Study of Maintenance Pemetrexed Versus Placebo after Induction Pemetrexed Plus Cisplatin for Advanced Nonsquamous Non–Small-Cell Lung Cancer

Cesare Gridelli, Filippo de Marinis, Jean-Louis Pujol et al. · Journal of Thoracic Oncology · 2012 · 55 citations · Full text

Oncology, Cancer Management, Resource Use +5

Primary lymphoepithelioma-like carcinoma of the lung

Ana Barroso, Rosete Nogueira, Hernâni Lencastre et al. · Lung Cancer · 2000 · 35 citations

Primary Lymphoepithelioma-like Carcinoma, Medicine, Multiple Pulmonary Nodule +5

: P2-235: Optimal duration of chemotherapy in non-small-cell lung cancer: multicenter, randomized, prospective clinical trial comparing 4 vs 6 cycles of carboplatin and gemcitabine

Fernando Barata, Bárbara Parente, Encarnação Teixeira et al. · Journal of Thoracic Oncology · 2007 · 30 citations · Full text

Oncology, Optimal Duration, Medicine +10

Second-line therapy for NSCLC in clinical practice: baseline results of the European SELECTTION observational study

Denis Moro‐Sibilot, A. Vergnenègre, Egbert F. Smit et al. · Current Medical Research and Opinion · 2010 · 17 citations